869 related articles for article (PubMed ID: 7630677)
1. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
[TBL] [Abstract][Full Text] [Related]
2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
3. Identification of two novel LDL receptor gene defects in French-Canadian pediatric population: mutational analysis and biochemical studies.
Assouline L; Leitersdorf E; Lambert M; Reshef A; Feoli-Fonseca JC; Levy E
Hum Mutat; 1997; 9(6):555-62. PubMed ID: 9195230
[TBL] [Abstract][Full Text] [Related]
4. Effect of apolipoprotein E genotype on lipid levels and response to diet in familial hypercholesterolemia.
Carmena-Ramón R; Real JT; Ascaso JF; Ordovás JM; Carmena R
Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):7-13. PubMed ID: 10812582
[TBL] [Abstract][Full Text] [Related]
5. Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent.
Wang J; Huff E; Janecka L; Hegele RA
Hum Mutat; 2001 Oct; 18(4):359. PubMed ID: 11668627
[TBL] [Abstract][Full Text] [Related]
6. FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations.
Dedoussis GV; Skoumas J; Pitsavos C; Choumerianou DM; Genschel J; Schmidt H; Stefanadis C
Eur J Clin Invest; 2004 Jun; 34(6):402-9. PubMed ID: 15200491
[TBL] [Abstract][Full Text] [Related]
7. HDL cholesterol levels in patients with molecularly defined familial hypercholesterolemia.
Miltiadous G; Cariolou MA; Elisaf M
Ann Clin Lab Sci; 2002; 32(1):50-4. PubMed ID: 11848618
[TBL] [Abstract][Full Text] [Related]
8. Relationship between apolipoprotein(a) phenotype, lipoprotein(a) concentration in plasma, and low density lipoprotein receptor function in a large kindred with familial hypercholesterolemia due to the pro664----leu mutation in the LDL receptor gene.
Soutar AK; McCarthy SN; Seed M; Knight BL
J Clin Invest; 1991 Aug; 88(2):483-92. PubMed ID: 1830890
[TBL] [Abstract][Full Text] [Related]
9. [Direct detection of mutations in the LDL receptor gene in patients with familial hypercholesterolemia].
Freiberger T; Kuhrová V; Kozák L; Soska V; Pekarík V; Mĕrínská L; Fajkusová L; Francová H
Cas Lek Cesk; 1998 Dec; 137(24):750-2. PubMed ID: 10081189
[TBL] [Abstract][Full Text] [Related]
10. Phenotype of heterozygotes for low-density lipoprotein receptor mutations identified in different background populations.
Tybjaerg-Hansen A; Jensen HK; Benn M; Steffensen R; Jensen G; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):211-5. PubMed ID: 15528480
[TBL] [Abstract][Full Text] [Related]
11. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population.
Real JT; Chaves FJ; Ejarque I; García-García AB; Valldecabres C; Ascaso JF; Armengod ME; Carmena R
Eur J Hum Genet; 2003 Dec; 11(12):959-65. PubMed ID: 14508510
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
[TBL] [Abstract][Full Text] [Related]
13. A double mutant [N543H+2393del9] allele in the LDL receptor gene in familial hypercholesterolemia: effect on plasma cholesterol levels and cardiovascular disease.
Castillo S; Reyes G; Tejedor D; Mozas P; Suarez Y; Lasuncion MA; Cenarro A; Civeira F; Alonso R; Mata P; Pocovi M;
Hum Mutat; 2002 Dec; 20(6):477. PubMed ID: 12442279
[TBL] [Abstract][Full Text] [Related]
14. Familial defective apolipoprotein B-100.
Hansen PS
Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
[TBL] [Abstract][Full Text] [Related]
15. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
[TBL] [Abstract][Full Text] [Related]
16. Lipid results of partial ileal bypass in patients with heterozygous, type II-A hyperlipoproteinemia. Program on the Surgical Control of the Hyperlipidemias.
Campos CT; Matts JP; Fitch LL; Speech JC; Long JM; Buchwald H
Surgery; 1990 Oct; 108(4):601-10; discussion 610-1. PubMed ID: 2120785
[TBL] [Abstract][Full Text] [Related]
17. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group.
Lambert M; Lupien PJ; Gagné C; Lévy E; Blaichman S; Langlois S; Hayden M; Rose V; Clarke JT; Wolfe BM; Clarson C; Parsons H; Stephure DK; Potvin D; Lambert J
Pediatrics; 1996 May; 97(5):619-28. PubMed ID: 8628597
[TBL] [Abstract][Full Text] [Related]
18. Moderate phenotypic expression of familial hypercholesterolemia in Tunisia.
Jelassi A; Slimani A; Jguirim I; Najah M; Abid A; Boughamoura L; Mzid J; Fkih M; Maatouk F; Rouis M; Varret M; Slimane MN
Clin Chim Acta; 2010 May; 411(9-10):735-8. PubMed ID: 20144596
[TBL] [Abstract][Full Text] [Related]
19. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.
Defesche JC; Pricker KL; Hayden MR; van der Ende BE; Kastelein JJ
Arch Intern Med; 1993 Oct; 153(20):2349-56. PubMed ID: 8215738
[TBL] [Abstract][Full Text] [Related]
20. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
